%.
The aim of WP4 is to define and standardise in vitro systems and their use in functional genomics studies of Chinese herbal medicines (CHM), including to:
- Develop a general strategy
- Establish criteria for selection of cell-based models for functional genomics research of CMH
- Employ these criteria to evaluate the quality of existing data and establish guidelines
- Obtain a comprehensive database of cell-based CHM studies
- Establish guidelines for using in silico tools
- Identify and define the scope, content and quality control procedures required in establishing and maintaining a comprehensive database of the information provided through in vitro studies.
WP4 Members:
Beneficiary members
Prof. Peter Hylands (WP4 Coordinator, King’s College London, UK)
Prof. Verena Dirsch (WP4 Deputy Coordinator, University of Vienna, Austria)
Dr. Alessandro Buriani (WP4 Assistant Coordinator, University of Padova, Italy)
Dr. Tai-Ping Fan (University of Cambridge, UK)
Dr. Qihe Xu (King’s College London, UK)
Dr. David Barlow (King’s College London, UK)
Dr. Maria Laura Garcia Bermejo (University Hospital Ramón y Cajal, Spain)
Prof. Jian Zhao Niu (Beijing University of Chinese Medicine, China)
Prof. Maria Carrara (University of Padova, Italy
Prof. Enrica Bosisio (University of Milan, Italy)
Prof. Angelika Vollmar (University of Munich, Germany)
Prof. Monique Simmonds (Royal Botanic Gardens, Kew, UK)
Dr. Jue Zhou (King’s College London, UK)
Dr. Atanas G. Atanasov (University of Vienna, Austria)
Non-beneficiary members
Dr. Mario Dell’Agli (University of Milan, Italy)
WP4 Contact:
Prof. Peter Hylands
WP4 Coordinator
King’s College London
Franklin – Wilkins Building
150 Stamford Street
London
SE1 9NN
UK
Tel: +44 207 848 4387
Fax: +44 207 848 4800
E-mail: [email protected]
Web page: http://kcl.ac.uk/schools/biohealth/research/pharmsci/groups/drug/pharmacognosy-intro.html
